A Bilateral Dispensing Clinical Trial of an Sapphire Lens Against Senofilcon A Toric for Astigmatism Lens

September 22, 2020 updated by: Coopervision, Inc.

A Bilateral Dispensing Clinical Trial of Sapphire Lens Against Senofilcon A Toric for Astigmatism Lens Over 2 Weeks

This study was conducted to evaluate the clinical performance of an investigational silicone-hydrogel lens against Senofilcon A toric lens.

The study results were not used for design validation of the investigational product.

Study Overview

Detailed Description

This will be a randomized, bilateral, 2-week cross-over, double-masked, dispensing study comparing the investigational test lens against the Senofilcon A Toric for Astigmatism control lens.

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Campbell, California, United States, 95008
        • Family Eye Care Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A person is eligible for inclusion in the study if they:

    1. Are at least 18 years of age and have full legal capacity to volunteer;
    2. Have read and signed an information consent letter;
    3. Are willing and able to follow instructions and maintain the appointment schedule;
    4. Are an adapted soft contact lens wearer;
    5. Require spectacle lens powers in both eyes;

      1. Sphere: between -1.75 to -6.00 diopters and
      2. Astigmatism: between -1.00 to -2.25 and
      3. Axis: 180 ± 20 degrees
    6. Are willing to wear contact lenses in both eyes;
    7. Have manifest refraction visual acuities (VA) equal to or better than logMAR (log of the minimum angle of resolution) equivalent of 20/25 in each eye;
    8. To be eligible for lens dispensing, the subject must have VA of logMAR equivalent of 20/30 or better in each eye with the study lenses and the investigator must judge the fit including toric orientation as acceptable.

Exclusion Criteria:

  • A person will be excluded from the study if they:

    1. Are participating in any concurrent clinical or research study;
    2. Have any known active* ocular disease and/or infection;
    3. Have a systemic condition that in the opinion of the investigator may affect a study outcome variable;
    4. Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
    5. Have known sensitivity to the diagnostic pharmaceuticals to be used in the study;
    6. Are pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit);
    7. Are aphakic;
    8. Have undergone refractive error surgery;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Sapphire contact lenses
Each subject randomized to wear either the Investigational lenses (test) or senofilcon A contact lenses (control) as a matched pair and cross over to the second matched pair.
Each subject randomized to wear either the test or control contact lenses as a matched pair and cross over to the second matched pair
ACTIVE_COMPARATOR: senofilcon A
Each subject randomized to wear either the Investigational lenses (test) or senofilcon A contact lenses (control) as a matched pair and cross over to the second matched pair.
Each subject randomized to wear either the test or control contact lenses as a matched pair and cross over to the second matched pair

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective Ratings for Comfort
Time Frame: Baseline (10 minutes post lens settling)
Scale 0-100; (0=Cannot be worn; 100=Cannot be felt ever)
Baseline (10 minutes post lens settling)
Subjective Ratings for Comfort
Time Frame: 2 weeks
Scale 0-100; (0=Cannot be worn; 100=Cannot be felt ever)
2 weeks
Subjective Ratings for Comfort Preference
Time Frame: Baseline (10 minutes post lens settling)
Subjective Ratings for Comfort Preference: Sapphire lens, senofilcon A lens, No preference
Baseline (10 minutes post lens settling)
Subjective Ratings for Comfort Preference
Time Frame: 2 weeks
Subjective Ratings for Comfort Preference: Sapphire lens, senofilcon A lens, No preference
2 weeks
Subjective Assessment of Visual Quality
Time Frame: Baseline (10 minutes post lens settling)
Subjective assessment of visual quality assessed on a Scale: 0-100 (0=Extremely poor vision all of the time; Cannot function; 100=Excellent vision all of the time)
Baseline (10 minutes post lens settling)
Subjective Assessment of Visual Quality
Time Frame: 2 weeks
Subjective assessment of visual quality assessed on a Scale: 0-100 (0=Extremely poor vision all of the time; Cannot function; 100=Excellent vision all of the time)
2 weeks
Subjective Assessment of Overall Satisfaction
Time Frame: Baseline (10 minutes post lens settling)
Subjective assessment of overall satisfaction on a Scale: 0-100: (0=Extremely dissatisfied; 100=Extremely satisfied)
Baseline (10 minutes post lens settling)
Subjective Assessment of Overall Satisfaction
Time Frame: 2 weeks
Subjective assessment of overall satisfaction on a Scale: 0-100: (0=Extremely dissatisfied; 100=Extremely satisfied)
2 weeks
Subjective Overall Preference
Time Frame: Baseline (10 minutes post lens settling)
Subjective Overall Preference: Sapphire lens, senofilcon A lens, No preference
Baseline (10 minutes post lens settling)
Subjective Overall Preference
Time Frame: 2 weeks
Subjective Overall Preference: Sapphire lens, senofilcon A lens, No preference
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michel Guillon, Ocular Technology Group

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (ACTUAL)

February 1, 2016

Study Completion (ACTUAL)

April 1, 2016

Study Registration Dates

First Submitted

September 4, 2015

First Submitted That Met QC Criteria

September 17, 2015

First Posted (ESTIMATE)

September 21, 2015

Study Record Updates

Last Update Posted (ACTUAL)

October 19, 2020

Last Update Submitted That Met QC Criteria

September 22, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CV-15-15

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Astigmatism

Clinical Trials on Sapphire contact lenses

3
Subscribe